According to the data from phase 3 clinical trials of the drug in 250 patients across 10 sites, the "drug works best in ...

The Directorate General of Health Services (DGHS), under the Central Drugs Standard Control Organisation (CDSCO), has ...

The decision follows the company’s claims that its drops could reduce the dependency on reading glasses for individuals ...

In an order issued on September 10, the Drugs Controller General of India (DCGI) said the Directorate had issued permission ...

The Drugs Controller General of India (DCGI) has suspended the approval granted to Mumbai-based Entod Pharmaceuticals for ...

Entod Pharmaceuticals denies making false claims about their new PresVu eye drops and plans to challenge the suspension by ...

The Central Drugs Standard Control Organisation (CDSCO) said that it was suspending its approval for the pilocarpine ...

DCGI suspends Entod Pharma`s eye drop permission for presbyopia treatment due to unapproved claims. The company will ...

DCGI suspends permission of Entod Pharma's ophthalmic solution PresVu: Our Bureau, New Delhi Wednesday, September 11, 2024, 17:20 Hrs [IST] The Central drug regulator has suspende ...

Entod Pharma to challenge DCGI's suspension of permission for PresVu in court: Our Bureau, New Delhi Thursday, September 12, 2024, 13:45 Hrs [IST] Entod Pharmaceuticals announced ...

In response to the various alleged misleading claims made by Entod Pharma in respect to its Opthalmologic product, Drugs ...

The Drugs Controller General of India (DCGI) stated in an order dated September 10 that the Directorate had approved on August 20 for the production and distribution of Pilocarpine Hydrochloride ...